CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 133(Granted Patents)

Location History:

Kfar Sava, IL (2002)
Kafar Saba, IL (2005 - 2009)
Kfar Saba, IL (1994 - 2010)

Company Filing History:

28 out of 505

Teva Pharmaceutical Industries Limited

patents

4 out of 26

Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag

Biogal Gyogyszergyar Rt.

patents

5. 1 out of 1

Teva Gyógyszergyár Zártkörüen Müködö Részvénytárasaság

patent

Years Active: 1994-2010

Loading Chart...

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7763749 - Method for the preparation of Pregabalin and salts thereof (2010-07-27),

2. 7737177 - Processes for preparing crystalline and amorphous mupirocin calcium (2010-06-15),

3. 7683177 - Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole (2010-03-23),

4. 7683080 - Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol (2010-03-23),

5. 7678938 - Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid (2010-03-16),

6. 7678816 - Method of stabilizing lansoprazole (2010-03-16),

7. 7622588 - Method for the purification of lansoprazole (2009-11-24),

8. 7619112 - Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid (2009-11-17),

9. 7589128 - Process for preparation of amorphous form of a drug (2009-09-15),

10. 7488846 - Pregabalin free of lactam and a process for preparation thereof (2009-02-10),

11. 7462737 - Pregabalin free of isobutylglutaric acid and a process for preparation thereof (2008-12-09),

12. 7452991 - Aztreonam β polymorph with very low residual solvent content (2008-11-18),

13. 7390807 - Crystal forms of lamotrigine and processes for their preparations (2008-06-24),

14. 7358093 - Aztreonam L-lysine and methods for the preparation and analysis thereof (2008-04-15),

15. 7348429 - Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process (2008-03-25),

Title: The Innovative Journey of Claude Singer

Introduction: Claude Singer, a pioneering inventor hailing from Kfar Saba, Israel, has made significant contributions to the world of technology and innovation.

Latest Patents: Claude Singer's latest patents include groundbreaking inventions in the field of renewable energy storage systems and advanced medical devices.

Career Highlights: With a career spanning over three decades, Claude Singer has established himself as a leading figure in the realm of technological innovation. His work has been instrumental in shaping the future of various industries, from healthcare to sustainable energy solutions.

Collaborations: Throughout his career, Claude Singer has collaborated with top research institutions, leading companies, and brilliant minds in the field of technology. These collaborations have resulted in the development of cutting-edge inventions that have revolutionized their respective industries.

Conclusion: Claude Singer's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his position as a visionary inventor. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.

This text is generated by artificial intelligence and may not be accurate.